Androgen receptor gene CAG repeat polymorphism and breast cancer risk in Iranian women: A case-control study

Breast Journal

Volumn 17, Issue 1, 2011, Pages 39-46

  Mehdipour, Parvin ^a   Pirouzpanah, Saeed ^a   Kheirollahi, Majid ^a   Atri, Morteza ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

CAG n repeats; androgen receptor; breast cancer; family history; polymorphism

Indexed keywords

ANDROGEN RECEPTOR;

ADULT; ALLELE; ARTICLE; BREAST CARCINOMA; CAG REPEAT; CANCER RISK; CONTROLLED STUDY; EXON; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HOMOZYGOSITY; HUMAN; IRAN; MAJOR CLINICAL STUDY;

ADULT; ALLELES; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; IRAN; LOGISTIC MODELS; POLYMORPHISM, GENETIC; RECEPTORS, ANDROGEN; TRINUCLEOTIDE REPEATS;

EID: 79251500677     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/j.1524-4741.2010.01031.x     Document Type: Article

References (32)

1. Hankinson SE, Willett WC, Manson J, et al. Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 1998; 90: 1292-99.
2. Page J, Colditz G, Rifai N, et al. Plasma adrenal androgens and risk of breast cancer in premenopausal women. Cancer Epidemiol Biomarkers Prev 2004; 13: 1032-36. (Pubitemid 38756714)
3. Nicolas Diaz-Chico B, Rodr′iguez F, Gonz′alez A, et al. Androgens and androgen receptors in breast cancer. J Steroid Biochem Mol Biol 2007; 105: 1-15.
4. Haiman C, Brown M, Hankinson S, et al. The androgen receptor CAG repeat polymorphism and risk of breast cancer in the Nurses' Health Study. Cancer Res 2002; 62: 1045-49.
5. Baniahmad A,. Nuclear hormone receptor co-repressors. J Steroid Biochem Mol Biol 2005; 93: 89-97.
6. Lilie E, Bernestein L, Ursin G,. The role of androgens and polymorphisms in the androgen receptor in the epidemiology of breast cancer. Breast Cancer Res 2003; 5: 164-73.
7. Zava D, McGuire W,. Estrogen receptors in androgen-induced breast tumor regression. Cancer Res 1977; 37: 1608-10. (Pubitemid 8098497)
8. Kazemi-Esfarjani P, Trifiro M, Pinsky L,. Evidence for a repressive function of the long polyglutamine tract in the human androgen receptor: possible pathogenetic relevance for the (CAG)n-expanded neuronopathies. Hum Mol Genet 1995; 4: 523-27.
9. Esteban E, Rodon N, Via M, et al. Androgen receptor CAG and GGC polymorphisms in Mediterraneans: repeat dynamics and population relationships. J Hum Genet 2006; 51: 129-36.
10. Sasaki M, Kaneuchi M, Sakuragi N, et al. The polyglycine and polyglutamine repeats in the androgen receptor gene in Japanese and Caucasian populations. Biochem Biophys Res Commun 2003; 312: 1244-47.
11. Giovannucci E, Stampfer M, Krithivas K, et al. The CAG repeat within the androgen receptor gene and its relationship to prostate cancer. Proc Natl Acad Sci USA 1997; 94: 3320-23.
12. McGrath M, Lee I, Hankinson S, et al. Androgen receptor polymorphisms and endometrial cancer risk. Int J Cancer 2006; 118: 1261-68.
13. Terry K, De Vivo I, Titus-Ernstoff L, Shih M, Cramer D,. Androgen receptor cytosine, adenine, guanine repeats, and haplotypes in relation to ovarian cancer risk. Cancer Res 2005; 65: 5974-81.
14. Liede A, Zhang W, De Leon Matsuda M, Tan A, Narod S,. Androgen receptor gene polymorphism and BC susceptibility in the Philippines. Cancer Epidemiol Biomarkers Prev 2003; 12: 848-52.
15. Giguere Y, Dewailly E, Brisson J, et al. Short polyglutamine tracts in the androgen receptor are protective against breast cancer in the general population. Cancer Res 2001; 61: 5869-74.
16. MacLean H, Brown R, Beilin J, Warne G, Zajac J,. Increased frequency of long androgen receptor CAG repeats in male breast cancers. Breast Cancer Res Treat 2004; 88: 239-46.
17. Wang W, John E, Ingles S,. Androgen receptor and prostate-specific antigen gene polymorphisms and breast cancer in African-American women. Cancer Epidemiol Biomarkers Prev 2005; 14: 2990-94.
18. Rebbeck T, Kantoff P, Krithivas K, et al. Modification of BRCA1-associated breast cancer risk by the polymorphic androgen-receptor CAG repeat. Am J Hum Genet 1999; 64: 1371-77.
19. Spurdle A, Antoniou A, Duffy D, et al. The androgen receptor CAG repeat polymorphism and modification of breast cancer risk in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res 2005; 7: R176-83.
20. Kadouri L, Easton D, Edwards S, et al. CAG and GGC repeat polymorphisms in the androgen receptor gene and breast cancer susceptibility in BRCA1/2 carriers and non-carriers. Br J Cancer 2001; 85: 36-40.
21. Menin C, Banna G, De Salvo G, et al. Lack of an association between androgen receptor CAG polymorphism and familial breast/ovarian cancer. Cancer Lett 2001; 168: 31-36.
22. Dunning A, McBride S, Gregory J, et al. No association between androgen or vitamin D receptor gene polymorphisms and risk of breast cancer. Carcinogenesis 1999; 20: 2131-35.
23. Atri M, Jafarimojarrad E, Javidroozi M, Mehdipour P,. Lack of association between early onset of breast cancer and numbers of affected relatives in an Iranian population. Fam Cancer 2003; 2: 117-18.
24. Atri M, Mehdipour P, Javidroozi M, Hosseini-Asl S, Jafarimojarrad E,. Linking histopathology and family history in breast cancer. Asian Pac J Cancer Prev 2002; 3: 33-39.
25. Tilley WD, Marcelli M, Wilson J, McPhaul M,. Characterization and expression of a cDNA encoding the human androgen receptor. Proc Natl Acad Sci USA 1989; 86: 327-31.
26. Mousavi S, Montazeri A, Mohagheghi M, et al. Breast cancer in Iran: an epidemiological review. Breast J 2007; 13: 383-91.
27. Gonzalez-Perez A, Drta F, Rodriguez G, et al. Increased risk of breast cancer in women bearing a combination of large CAG and GGN repeats in exon 1 of the androgen receptor gene. Eur J Cancer 2007; 43: 2373-80.
28. Spurdle A, Dite G, Chen X, et al. Androgen receptor exon 1 CAG repeat length and breast cancer in women before age forty years. J Natl Cancer Ins 1999; 91: 961-66.
29. Cox D, Blanche H, Pearce C, et al. A comprehensive analysis of the androgen receptor gene and risk of breast cancer: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3). Breast Cancer Res 2006; 20: 1-19.
30. Suter N, Malone K, Daling J, Doody D, Ostrander E,. Androgen receptor (CAG)n and (GGC)n polymorphisms and breast cancer risk in a population-based case-control study of young women. Cancer Epidemiol Biomarkers Prev 2003; 12: 127-35.
31. Hsing A, Chokkalingam A, Gao Y, et al. Polymorphic CAG/CAA repeat length in the AIB1/SRC-3 gene and prostate cancer risk: a population-based case-control study. Cancer Epidemiol Biomarkers Prev 2002; 11: 337-41.
32. Mehdipour P, Atri M, Jafarimojarrad E, Hosseini-Asl S, Javidroozi M,. Laddering through pedigrees: family history of malignancies in primary breast cancer patients. Asian Pac J Cancer Prev 2003; 4: 185-92.